Meyka Pro banner
Stereotaxis, Inc.

Stereotaxis, Inc. (STXS) Stock Overview

Explore Stereotaxis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

STXSAMEX
HealthcareMedical - Equipment & Services
$1.42
$0.06(4.41%)
U.S. Market opens in 49h 50m

Stereotaxis, Inc. (STXS)

Meyka AI Score

Z

Key Financials

Market Cap139M
P/E Ratio-5.84
EPS (TTM)$-0.17
ROE-1.53%
Fundamental Analysis

AI Price Forecasts

1 Month$1.73
3 Months$1.94
1 Year Target$2.39

STXS Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of Stereotaxis, Inc. (AMEX: STXS) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Stereotaxis, Inc.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of STXS on the AMEX shows an RSI of 44.55, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.39 for the AMEX listing.

Key metrics behind Stereotaxis, Inc.'s AMEX-traded stock include a P/E ratio of -5.84 and a market capitalization of 139M. Combined with our AI analysis, these give both institutional and retail investors a clear view of STXS on the AMEX.

Price Performance (AMEX: STXS)

1-Day Change
4.34%
5-Day Change
6.69%
1-Month Change
-22.03%
3-Month Change
-25.32%
6-Month Change
-30.10%
Year-to-Date (YTD) Change
-38.30%
1-Year Change
-35.21%
3-Year Change
-5.40%
5-Year Change
-84.37%
All-Time (Max) Change
-98.01%

Contact Information

314 678 6100
710 North Tucker Boulevard, St. Louis, MO, 63101

Company Facts

1,310 Employees
IPO DateAug 12, 2004
CountryUS
Actively Trading

Frequently Asked Questions